Elad Arad
Impact in
- Biomaterials top 10%
- Supramolecular Self-Assembly in Materials
- Physiology top 10%
- Alzheimer's disease research and treatments
Papers in
-
- Protein Structure and Dynamics 6
- Chemical Synthesis and Analysis 4
- Prion Diseases and Protein Misfolding 3
- Physiology 12
- Alzheimer's disease research and treatments 12
- Co-authors
- Raz Jelinek (21 shared papers)Hanna Rapaport (10 shared papers)Ehud Gazit (7 shared papers)Sofiya Kolusheva (4 shared papers)Susanta Kumar Bhunia (3 shared papers)Ravit Malishev (2 shared papers)Shira Shaham‐Niv (2 shared papers)Daniel Segal (5 shared papers)
- Journals
- Chemical Communications (3 papers)Nature Communications (2 papers)Advanced Therapeutics (2 papers)ACS Nano (2 papers)Biomacromolecules (1 paper)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Elad Arad
21 papers receiving 528 citations
Peers
Comparison fields: 5 of 72
- Biomaterials 153
- Physiology 191
- Molecular Biology 236
- Materials Chemistry 150
- Molecular Medicine 15
Countries citing papers authored by Elad Arad
This map shows the geographic impact of Elad Arad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elad Arad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elad Arad more than expected).
Fields of papers citing papers by Elad Arad
This network shows the impact of papers produced by Elad Arad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elad Arad. The network helps show where Elad Arad may publish in the future.
Co-authors
The 25 scholars most cited alongside Elad Arad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 110 | |
| 2 | 2020 | 103 | |
| 3 | 2019 | 56 | |
| 4 | 2021 | 34 | |
| 5 | 2019 | 33 | |
| 6 | 2018 | 32 | |
| 7 | 2022 | 28 | |
| 8 | 2022 | 25 | |
| 9 | 2023 | 19 | |
| 10 | 2021 | 19 | |
| 11 | 2019 | 15 | |
| 12 | 2019 | 15 | |
| 13 | 2018 | 12 | |
| 14 | 2024 | 9 | |
| 15 | 2024 | 8 | |
| 16 | 2025 | 4 | |
| 17 | 2017 | 4 | |
| 18 | 2024 | 2 | |
| 19 | 2021 | 1 | |
| 20 | 2022 | 1 |
About Elad Arad
Elad Arad is a scholar working on Molecular Biology, Physiology, Biomaterials, Organic Chemistry and Materials Chemistry, having authored 21 papers that have together received 531 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (12 papers), Supramolecular Self-Assembly in Materials (10 papers), Protein Structure and Dynamics (6 papers), Chemical Synthesis and Analysis (4 papers), Prion Diseases and Protein Misfolding (3 papers), Nanocluster Synthesis and Applications (2 papers), Carbon and Quantum Dots Applications (2 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Biomaterials (153 citations), Physiology (191 citations), Molecular Biology (236 citations), Materials Chemistry (150 citations) and Molecular Medicine (15 citations). Elad Arad has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Raz Jelinek, Hanna Rapaport, Ehud Gazit, Sofiya Kolusheva, Susanta Kumar Bhunia, Ravit Malishev, Shira Shaham‐Niv, Daniel Segal, Hamutal Engel and Jürgen Jopp. Their work appears in journals such as Chemical Communications, Nature Communications, Advanced Therapeutics, ACS Nano and Biomacromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.